Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT01293617 Completed - Healthy Volunteers Clinical Trials

Blackberry Intake and Biomarkers of Cancer Risk

Start date: January 2011
Phase: N/A
Study type: Interventional

Berry components have been shown to influence cancer processes in cell culture studies. The investigators will conduct a study to investigate if blackberries influence the same cancer processes in a human feeding study.

NCT ID: NCT01291563 Completed - Healthy Volunteer Clinical Trials

TMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Interval Under Fed Conditions

Start date: February 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of an 800-mg single dose of TMC207 on the QT/QTc interval in healthy volunteers.

NCT ID: NCT01290198 Completed - Healthy Volunteers Clinical Trials

Role of Epoxy-eicosatrienoic Acids in Post-occlusive Hyperemia and Thermal Hyperemia

EETY
Start date: February 2011
Phase: N/A
Study type: Interventional

The objective of this proof of concept study is to assess the involvement of epoxy-eicosatrienoic acids (EETs) in post-occlusive hyperemic and thermal hyperemia responses, and the interaction between nitric oxide (NO) and EETs, using the latest methods for the study of functional microcirculation.

NCT ID: NCT01288677 Completed - Healthy Volunteer Clinical Trials

TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers

Start date: January 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the pharmacokinetics, safety, and tolerability of single oral doses of TMC649128 in healthy volunteers. Pharmacokinetics (PK) means how the drug is absorbed into the bloodstream, distributed in the body, and eliminated from the body.

NCT ID: NCT01287091 Completed - Healthy Volunteer Clinical Trials

A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the Tablet

Start date: October 14, 2010
Phase: Phase 1
Study type: Interventional

This will be a single-center, open-label, 3 part study. The study is designed to determine the relative bioavailability of GDC-0980 capsule and tablet formulations under fasting conditions, the effects of a high-fat (fed) meal on the pharmacokinetics of the GDC-0980 tablet, and the effects of rabeprazole on the pharmacokinetics of the GDC-0980 tablet in the presence or absence of a high-fat meal.

NCT ID: NCT01285596 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex

Start date: March 2009
Phase: Phase 1
Study type: Interventional

Young and elderly, male and female subjects are each given 2 different doses of mirabegron for 7 days each. Levels of mirabegron in the blood are assessed.

NCT ID: NCT01284868 Completed - Healthy Volunteers Clinical Trials

A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.

Start date: July 2009
Phase: Phase 1
Study type: Interventional

To explore what is driving heart-rate increases after dosing with mirabegron. Subjects will be given a beta-blocker at the same time as mirabegron.

NCT ID: NCT01280175 Completed - Healthy Volunteers Clinical Trials

Foster With or Without Charcoal Block or Aerochamber Plus

Start date: December 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the systemic exposure of BDP, its metabolite beclomethasone 17-monopropionate (B17MP) and formoterol after inhalation of BDP/Formoterol 100/6 µg pMDI combination (CHF1535) using the standard actuator and charcoal block technique or using a Spacer (AeroChamber Plus, Trudell) in comparison with inhalation using the standard actuator

NCT ID: NCT01277718 Completed - Healthy Volunteer Clinical Trials

A Study to Evaluate the Effect of a Proton-Pump Inhibitor (Rabeprazole) on the Relative Bioavailability of GDC 0973 in Healthy Subjects

Start date: January 2011
Phase: Phase 1
Study type: Interventional

This is a Phase 1, single-center, open-label, randomized, 3-period, 2-sequence crossover study of GDC-0973 in healthy subjects to evaluate the effect of the proton pump inhibitor (PPI) rabeprazole on the relative bioavailability of GDC-0973 in healthy subjects when administered in the fed or fasted states.

NCT ID: NCT01275157 Completed - Healthy Volunteers Clinical Trials

Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects

Start date: January 2011
Phase: Phase 1
Study type: Interventional

This is a single dose study of radiolabeled [14C]-LY2452473 in healthy male volunteers to study the absorption, distribution, metabolism, and elimination of LY2452473. This study is for research purposes only and is not intended to treat any medical condition.